MCID: LYM019
MIFTS: 58

Lymphosarcoma

Categories: Rare diseases, Immune diseases, Cancer diseases

Aliases & Classifications for Lymphosarcoma

Summaries for Lymphosarcoma

MalaCards based summary : Lymphosarcoma, also known as malignant lymphoma, is related to testicular lymphoma and reticulosarcoma. An important gene associated with Lymphosarcoma is BCL6 (B Cell CLL/Lymphoma 6), and among its related pathways/superpathways are B cell receptor signaling pathway (KEGG) and B Cell Receptor Signaling Pathway (sino). The drugs Dopamine and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and bone, and related phenotypes are cellular and growth/size/body region

Wikipedia : 72 Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The... more...

Related Diseases for Lymphosarcoma

Diseases related to Lymphosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 137)
# Related Disease Score Top Affiliating Genes
1 testicular lymphoma 31.7 BCL6 PTPRC
2 reticulosarcoma 29.8 BCL6 PTPRC
3 mediastinal malignant lymphoma 12.1
4 burkitt lymphoma 11.5
5 lymphoproliferative syndrome, x-linked, 1 11.4
6 mantle cell lymphoma 11.3
7 breast lymphoma 11.2
8 lymphoproliferative syndrome 2 11.0
9 diffuse large b-cell lymphoma 10.9
10 lymphoma, small cleaved-cell, diffuse 10.9
11 lymphoproliferative syndrome, x-linked, 2 10.9
12 leukemia 10.4
13 testis seminoma 10.3 DNMT3A PTPRC
14 glucosephosphate dehydrogenase deficiency 10.2 G6PD H6PD
15 meningococcal infection 10.2 G6PD GSR
16 heart lymphoma 10.2 BCL6 PTPRC
17 nodular lymphocyte predominant hodgkin lymphoma 10.2 BCL6 PTPRC
18 bone lymphoma 10.2 BCL6 CD22
19 plasmablastic lymphoma 10.1 BCL6 PTPRC
20 testicular torsion 10.1 BCL2 GSR
21 senile cataract 10.1 G6PD GSR
22 epidural neoplasm 10.1 BCL6 PTPRC
23 lymphoma 10.1
24 small intestine lymphoma 10.0 CD22 CTSL PTPRC
25 lung lymphoma 10.0 BCL6 CD22
26 high grade b-cell lymphoma with myc and/ or bcl2 and/or bcl6 rearrangement 10.0 BCL2 BCL6
27 nodal marginal zone b-cell lymphoma 10.0 BCL2 BCL6
28 follicular lymphoma 1 10.0 BCL2 BCL6
29 intravascular large b-cell lymphoma 10.0 BCL2 BCL6
30 hypercalcemia, infantile, 1 10.0
31 colon lymphoma 10.0 BCL6 CD22 PTPRC
32 primary central nervous system lymphoma 10.0 BCL2 BCL6
33 human herpesvirus 8 9.9 BCL2 BCL6
34 gastric lymphoma 9.9 BCL2 BCL6
35 mature b-cell neoplasm 9.9 BCL6 PTPRC
36 hepatitis 9.9
37 mediastinitis 9.9
38 rhabdoid cancer 9.8 PTPRC SMARCA4
39 blood group, i system 9.8
40 ataxia and polyneuropathy, adult-onset 9.8
41 inflammatory bowel disease 9.8
42 hypersplenism 9.8
43 neuropathy 9.8
44 marginal zone b-cell lymphoma 9.8 BCL2 BCL6
45 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 9.7
46 b-cell expansion with nfkb and t-cell anergy 9.7
47 acute leukemia 9.7
48 lymphoid leukemia 9.7
49 thrombosis 9.7
50 hemopericardium 9.7

Graphical network of the top 20 diseases related to Lymphosarcoma:



Diseases related to Lymphosarcoma

Symptoms & Phenotypes for Lymphosarcoma

MGI Mouse Phenotypes related to Lymphosarcoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.01 BCL2 NR3C1 BCL6 PTPRC CD22 DNMT3A
2 growth/size/body region MP:0005378 9.92 G6PD H6PD BCL2 NR3C1 BCL6 PTPRC
3 endocrine/exocrine gland MP:0005379 9.91 BCL2 H6PD NR3C1 BCL6 PTPRC DNMT3A
4 hematopoietic system MP:0005397 9.86 BCL2 NR3C1 BCL6 PTPRC CD22 DNMT3A
5 homeostasis/metabolism MP:0005376 9.81 H6PD BCL2 NR3C1 BCL6 PTPRC RRP8
6 mortality/aging MP:0010768 9.61 G6PD BCL2 NR3C1 BCL6 PTPRC CD22
7 muscle MP:0005369 9.1 BCL2 H6PD NR3C1 BCL6 DNMT3A SMARCA4

Drugs & Therapeutics for Lymphosarcoma

Drugs for Lymphosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 950)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 3 51-61-6, 62-31-7 681
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
3
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 23214-92-8 31703
4
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 65271-80-9 4212
5
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 20830-81-3 30323
6
Vinblastine Approved Phase 4,Phase 3,Phase 2,Phase 1 865-21-4 241903 13342
7
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2068-78-2, 57-22-7 5978
8
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
9
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
10
Idarubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 58957-92-9 42890
11
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-94-4 6253
12
Teniposide Approved Phase 4,Phase 3,Phase 2,Phase 1 29767-20-2 34698
13
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1959-05-2, 59-05-2 126941
14
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 148-82-3 460612 4053
15
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
16
Iron Approved Phase 4,Phase 3,Phase 1,Phase 2 7439-89-6 23925
17
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 95058-81-4 60750
18
Dasatinib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 302962-49-8 3062316
19
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21679-14-1, 75607-67-9 30751
20
Vidarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24356-66-9 21704 32326
21
Busulfan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
22
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
23
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 657311 5754
24
Bleomycin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 11056-06-7 5360373
25
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3778-73-2 3690
26
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
27
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
28
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-75-2 4033
29
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 43805 6857599 5310940 9887054
30
Mesna Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3375-50-6 598
31
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4342-03-4 5351166
32
Bexarotene Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 153559-49-0 82146
33
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 81103-11-9 84029
34
Granisetron Approved, Investigational Phase 4,Phase 2 109889-09-0 3510
35
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 159351-69-6 6442177
36
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
37
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
38
Tropisetron Approved, Investigational Phase 4 105826-92-4, 89565-68-4 5595
39
Amifostine Approved, Investigational Phase 4,Phase 2,Phase 1 20537-88-6 2141
40 Thiotepa Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 52-24-4 5453
41
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
42
Aprepitant Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 170729-80-3 6918365 151165
43
Denileukin diftitox Approved, Investigational Phase 4,Phase 2,Phase 1 173146-27-5
44
Entecavir Approved, Investigational Phase 4,Phase 2 142217-69-4 153941
45
Palonosetron Approved, Investigational Phase 4,Phase 2 135729-61-2, 135729-56-5, 119904-90-4 148211
46
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2 2216-51-5 16666
47
Cladribine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4291-63-8 20279
48
Crizotinib Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
49
Thioguanine Approved Phase 4,Phase 3,Phase 2,Phase 1 154-42-7 2723601
50
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741

Interventional clinical trials:

(show top 50) (show all 6292)

# Name Status NCT ID Phase Drugs
1 Lymphoma in the Orbit Unknown status NCT01302912 Phase 4
2 Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. Unknown status NCT00429065 Phase 4 Rituximab
3 Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults Unknown status NCT00797810 Phase 4 Rituximab
4 ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors Unknown status NCT02290132 Phase 4 Rabbit Anti-human Thymocyte Globulin (ATG)
5 Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET Unknown status NCT00188149 Phase 4 Combined chemotherapy (ABVD, BACOPP-D)
6 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Unknown status NCT02347878 Phase 4 Aprepitant
7 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
8 Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Unknown status NCT02690922 Phase 4 Dasatinib;prednisone;dexamethasone;methotrexate
9 HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL Unknown status NCT01873807 Phase 4 IDA;CTX;VP-16
10 Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 Unknown status NCT00222612 Phase 4 Standard childhood UK ALL protocol;Intensified treatment including Capizzi maintenance
11 Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses Unknown status NCT00192673 Phase 4 PEG-asparaginase
12 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4 Cyclophosphamide;Dexamethasone;Vincristine;daunorubicin;Asparaginase;Methotrexate;Cytarabine;Mercaptopurine;G-CSF;Vindesine;VP16;Prednisolone;Adriamycin;Thioguanine;VM26;Idarubicin;Fludarabine;Cladribine
13 German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT00198978 Phase 4 Cyclophosphamide;Dexamethasone / Prednisolone;Cytarabine;Idarubicin;Granulocyte-Colony-Stimulating Factor;Mercaptopurine;Methotrexate;Rituximab;HDARAC;Vincristine;Depocyte;Asparaginase
14 Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Unknown status NCT01990807 Phase 4 Idarubicin(IDA)
15 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Unknown status NCT00274885 Phase 4 oxaliplatin
16 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. Completed NCT00440817 Phase 4
17 Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America Completed NCT02559583 Phase 4
18 Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands Completed NCT00731536 Phase 4
19 Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma Completed NCT00168727 Phase 4 ibritumomab tiuxetan (Zevalin®)
20 An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma Completed NCT01833039 Phase 4 Ibrutinib
21 Treatment of Peripheral T-cell Lymphoma Completed NCT01664975 Phase 4 GDPT regimen;CHOP regimen
22 PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Completed NCT02805218 Phase 4 PEG-rhG-CSF
23 Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) Completed NCT00211198 Phase 4 ONTAK (denileukin difitox, DAB389IL-2)
24 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients Completed NCT02108444 Phase 4
25 Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) Completed NCT01007448 Phase 4 bexarotene;bexarotene
26 Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Completed NCT00969462 Phase 4 Doxorubicin
27 MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. Completed NCT00430352 Phase 4 rituximab [MabThera/Rituxan]
28 Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Completed NCT01164475 Phase 4 Granulocyte-colony stimulating factor (G-CSF);Fixed Dose Plerixafor;Weight-Based Plerixafor
29 German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults Completed NCT00199017 Phase 4 Dexamethasone/Prednisolone;Cyclophosphamide;Vincristine;Daunorubicin;Asparaginase;G-CSF;Mercaptopurine;Cytarabine;Methotrexate;VP16;Vindesine;Adriamycin;Thioguanine;HDARAC;Cladribine
30 Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma Completed NCT01124526 Phase 4 Rituximab Fludarabine Cyclophosphamide
31 Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) Completed NCT00153530 Phase 4 methotrexate
32 Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B Completed NCT00926757 Phase 4 Entecavir prophylaxis;Therapeutic entecavir
33 Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma Completed NCT01569724 Phase 4
34 An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Completed NCT02782845 Phase 4 Chemotherapy;Immunochemotherapy;Pegfilgrastim
35 LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) Completed NCT00466258 Phase 4 R-CHOP;Highly active antiretroviral therapy;Central nervous system (CNS) prophylaxis;Prophylaxis of opportunistic infections and support treatment
36 Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients Completed NCT00050999 Phase 4 ONTAK
37 Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients Completed NCT00051012 Phase 4 ONTAK
38 Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma Completed NCT00090038 Phase 4 rituximab
39 Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy Completed NCT00230217 Phase 4 Rasburicase (SR29142)
40 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
41 Prevention of CHOP-induced Chronic Cardiotoxicity Completed NCT00162955 Phase 4 Valsartan
42 Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A Completed NCT00221039 Phase 4 Methoxsalen+ECP
43 Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Completed NCT01418430 Phase 4 CHOP-daclizumab
44 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
45 Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia Completed NCT01374373 Phase 4
46 Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy Completed NCT00524407 Phase 4 Epoetin alfa
47 Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture Completed NCT00808171 Phase 4 Livopan;Livopan;EMLA
48 ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia Completed NCT00114348 Phase 4
49 DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Completed NCT00029523 Phase 4 Intrathecal (injected into the spinal fluid) DepoCyt;Intrathecal methotrexate;Intrathecal cytarabine (also known as ara-C)
50 AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Completed NCT00415103 Phase 4 Aprepitant;Palonosetron;Granisetron

Search NIH Clinical Center for Lymphosarcoma

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Genetic Tests for Lymphosarcoma

Anatomical Context for Lymphosarcoma

MalaCards organs/tissues related to Lymphosarcoma:

38
B Cells, T Cells, Bone, Bone Marrow, Lung, Myeloid, Nk Cells

Publications for Lymphosarcoma

Articles related to Lymphosarcoma:

(show top 50) (show all 536)
# Title Authors Year
1
Acute Lameness in a Roller Pigeon ( Columba livia ) with Multicentric Lymphosarcoma. ( 28665728 )
2017
2
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells. ( 28126663 )
2017
3
Cytomegalovirus retinitis in a patient with secondary acute lymphosarcoma leukemia undergoing allogeneic hematopoietic stem-cell transplantation: A rare case report: a care-compliant article. ( 28489788 )
2017
4
Association of BoLA-DRB3.2 Alleles with BLV Infection Profiles (Persistent Lymphocytosis/Lymphosarcoma) and Lymphocyte Subsets in Iranian Holstein Cattle. ( 26782666 )
2016
5
South African report of first case of chromoblastomycosis caused by Cladosporium (syn Cladophialophora) carrionii infection in a cat with feline immunodeficiency virus and lymphosarcoma. ( 25425600 )
2015
6
Massive Localized Lymphedema in the Morbidly Obese Patient: A Clinical Entity Mimicking Lymphosarcoma. ( 26367787 )
2015
7
Focal thoracolumbar spinal cord lymphosarcoma in a ferret (Mustela putorius furo). ( 24982519 )
2014
8
Monoclonal hyperglobulinemia in lymphosarcoma in a cockatiel (Nymphicus hollandicus) and a blue and gold macaw (Ara ararauna). ( 25055643 )
2014
9
Cloacolithiasis and intestinal lymphosarcoma in an African black-footed penguin (Spheniscus demersus). ( 25000718 )
2014
10
Feline small cell lymphosarcoma versus inflammatory bowel disease: diagnostic challenges. ( 23677821 )
2013
11
Dynamics of oxidative modification of proteins and specific structural features of blood plasma from animals with Pliss lymphosarcoma. ( 23658922 )
2013
12
Lymphosarcoma in a captive bonnethead shark, Sphyrna tiburo (L.). ( 23121332 )
2013
13
Feline small cell lymphosarcoma versus inflammatory bowel disease: treatment and prognosis. ( 23814916 )
2013
14
The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy. ( 25221731 )
2013
15
Activation of Cathepsins B and L in Mouse Lymphosarcoma Tissue under the Effect of Cyclophosphamide Is Associated with Apoptosis Induction and Infiltration by Mononuclear Phagocytes. ( 24319737 )
2013
16
A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression. ( 23840536 )
2013
17
Idiopathic hemorrhagic pericardial effusion as a precursor to epicardial lymphosarcoma in three cows. ( 22676351 )
2012
18
Thymic lymphosarcoma with brain involvement in a Holstein heifer. ( 22785125 )
2012
19
Respiratory distress due to retropharyngeal and neck swelling in a horse with mediastinal lymphosarcoma. ( 22581725 )
2012
20
The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma. ( 23251817 )
2012
21
Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein. ( 22803083 )
2012
22
Ultrasonographic findings in a cow with abomasal lymphosarcoma: case report. ( 21612590 )
2011
23
Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement. ( 21355805 )
2011
24
Lymphosarcoma associated with Heterobilharzia americana infection in a dog. ( 21908377 )
2011
25
What is your diagnosis? Lymphosarcoma. ( 22216725 )
2011
26
Proline rich polypeptide (PRP-1) increases the superoxide-producing and ferrihemoglobin reducing activities of cytochrome B(558) isoforms from human lymphosarcoma tissue cells. ( 21213045 )
2011
27
Computed tomography of a cat with primary intratracheal lymphosarcoma before and after systemic chemotherapy. ( 22058360 )
2011
28
Signalment and clinical complaints initiating hospital admission, methods of diagnosis, and pathological findings associated with bovine lymphosarcoma (112 cases). ( 20492490 )
2010
29
Morphologic changes in the tumor and liver in mice with transplanted RLS40 lymphosarcoma during increase of its drug resistance. ( 21113505 )
2010
30
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy. ( 20470373 )
2010
31
What is your diagnosis? Pulmonary lymphosarcoma in a dog. ( 20392175 )
2010
32
Multicentric T-cell lymphosarcoma in a white-tailed deer (Odocoileus virginianus). ( 19617490 )
2009
33
Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype. ( 20848912 )
2009
34
[The state of enzymatic redox system of glutathione in the blood of patients with lymphosarcoma (non-Hodgkin's lymphoma]. ( 19642581 )
2009
35
Immunophenotyping of lymphosarcoma in South American camelids on six British premises. ( 17307369 )
2008
36
Diffuse intestinal T-cell lymphosarcoma in a yellow-naped Amazon parrot (Amazona ochrocephala auropalliata). ( 18776105 )
2008
37
Canine lymphosarcoma: overcoming diagnostic obstacles and introduction to the latest diagnostic techniques. ( 18390105 )
2008
38
Comparison of core needle biopsy and fine-needle aspiration of enlarged peripheral lymph nodes for antemortem diagnosis of enzootic bovine lymphosarcoma in cattle. ( 17223756 )
2007
39
Managing the canine lymphosarcoma patient in general practice. ( 17966344 )
2007
40
Association between renal hypoechoic subcapsular thickening and lymphosarcoma in cats. ( 17691636 )
2007
41
Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma. ( 17339285 )
2007
42
Cutaneous lymphosarcoma in a double yellow-headed Amazon parrot (Amazona ochrocephala oratrix). ( 18351007 )
2007
43
Atypical presentation of cutaneous T-cell lymphosarcoma in a 19-month-old Holstein heifer. ( 17436911 )
2007
44
Large granular intestinal lymphosarcoma and leukemia in a dog. ( 17824330 )
2007
45
Multicentric T-cell lymphosarcoma in an alpaca. ( 16427596 )
2006
46
Standing thoracoscopy in the diagnosis of lymphosarcoma in a horse. ( 16963717 )
2006
47
Hypernatremia and hyperlipidemia in a dog with central nervous system lymphosarcoma. ( 16955835 )
2006
48
What is your diagnosis? A case of intervertebral disc protrusion in a cat: lymphosarcoma. ( 16438699 )
2006
49
Role of tumor-derived transforming growth factor-beta1 (TGF-beta1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma. ( 15726358 )
2005
50
Choanal lymphosarcoma in a 7-year-old golden retriever: diagnosis and treatment. ( 15825520 )
2005

Variations for Lymphosarcoma

Expression for Lymphosarcoma

Search GEO for disease gene expression data for Lymphosarcoma.

Pathways for Lymphosarcoma

GO Terms for Lymphosarcoma

Biological processes related to Lymphosarcoma according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell growth GO:0030308 9.5 BCL2 BCL6 SMARCA4
2 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.49 BCL2 SMARCA4
3 cellular response to glucose starvation GO:0042149 9.48 BCL2 RRP8
4 T cell differentiation GO:0030217 9.46 BCL2 PTPRC
5 covalent chromatin modification GO:0016569 9.46 DNMT3A NR3C1 RRP8 SMARCA4
6 B cell proliferation GO:0042100 9.43 BCL2 PTPRC
7 response to gamma radiation GO:0010332 9.4 BCL2 PTPRC
8 negative regulation of reactive oxygen species metabolic process GO:2000378 9.37 BCL2 G6PD
9 pentose-phosphate shunt GO:0006098 9.26 G6PD H6PD
10 NADP metabolic process GO:0006739 8.96 G6PD H6PD
11 positive regulation of B cell proliferation GO:0030890 8.8 BCL2 BCL6 PTPRC

Molecular functions related to Lymphosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 carbohydrate binding GO:0030246 9.33 CD22 G6PD H6PD
2 NADP binding GO:0050661 9.13 G6PD GSR H6PD
3 glucose-6-phosphate dehydrogenase activity GO:0004345 8.62 G6PD H6PD

Sources for Lymphosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....